Background: The objective was to evaluate the fPSA for discriminate between prostate cancer patients (PCa) and benign prostatic hyperplasia (BPH) depend on the variations in PSA fucosylation (Fucα1-6/3GlcNAc
differentiation of androgen-dependent cells and increases the risk for development of benign prostatic hyperplasia and prostate cancer. The recovery of testosterone production and regeneration helps make a decrease…
Background: Prostatic artery embolization is one of the most recent emerging and sophisticated interventional radiology procedures. Prostatic artery embolization is a minimally invasive procedure in management of lower…
Background: There is high mortality from prostate cancer in Nigeria. Lack of awareness and low screening uptake are associated with this poor outlook. There is need to develop strategies ... improve uptake of screening…
Background: Transurethral Microwave Thermotherapy (TUMT) has shown limited efficacy as a treatment for prostate cancer, mainly because of the inability of microwaves to reach the peripheral region of the prostate…
Introduction: A prostate cancer case in sub-Saharan Africa is rising. In Sudan, prostate cancer ranks third at after breast cancer. The nuclear deoxyribonucleic acid content has been shown ... great prognostic value in…
Metastatic prostate cancer is frequently presented as cancer of unknown origin. To confirm the prostatic origin, prostatespecific antigen (PSA), prostein, HoxB13, and NKX3.1 are frequently used. However, these markers…
High-intensity focused ultrasound (HIFU) treatment for prostate cancer and benign prostatic hyperplasia (BPH) was utilized worldwide owing to benefits of non-invasive treatment, fast recovery time, and low rate…
Prostate cancer is one of the most malignancies affecting men. Recurrence of prostate cancer is usually assessed by elevating serum Prostate-Specific Antigen (PSA) level. These days, new radiotracers using ... Emission…
therapy with the same vector. This concept is utilized in few malignancies and prostate cancer is one of them. PSMA expression in normal and other tumor is less than prostate ... staging . Besides evaluation of…
Allenâ??s therapeutic device (DATD) is a completely new treatment for benign prostatic hyperplasia (BPH). Nearly one in four men will suffer from BPH over their lifetime. BPH isnâ ... year empirical data show that men…
Allen’s therapeutic device (DATD) is a completely new treatment for benign prostatic hyperplasia (BPH). Nearly one in four men will suffer from BPH over their lifetime ... year empirical data show that men around the…
evaluate whether or not f/t PSA and PSAD had any diagnostic contribution to prostate cancer (pCa) detection in patients that had prostate volumes ≥ 100 cc.Material and Methods: The medical ... records of transrectal…
provide a side effects free treatment for common chronic urological diseases, such as benign prostatic hyperplasia (BPH), chronic prostatitis and kidney stone disease. TT and DATD received US patent ... heat, to the…
provide a side effects free treatment for common chronic urological diseases, such as benign prostatic hyperplasia (BPH), chronic prostatitis and kidney stone disease. TT and DATD received a US patent ... heat, to the…
Introduction: The effect of serum steroidal sex hormones on benign prostatic hyperplasia was evaluated with different levels of serum testosterone epidemiologically. Methods: Between April 2015 and February 2017, 194…
Purpose: To probe the effective treatment for patients with Begin Prostate Hyperplasia (BPH) along with bladder stones with Plasmakinetic Resection of Prostate combining with Transurethral Nephrolithotripsy by Pneumatic…
current imaging methods for the prostate cancer diagnosis are complicated and partially invasive. Therefore, a key challenge for prostate cancer detection is to use a simple and non-invasive method ... Imaging plays a…
Objective: The present study aims to investigate the risk of developing second primary prostate cancer after treating initial primary prostate cancer and to determine the role played by different variables ... have…
Prostate Cancer is one of the common cancers in the world. It could primarily disseminate to the bone and can lead to death. In order to address its life threatening ... individual methods reported in literature and…
protective effect was found in normal human fibroblasts. NSC 631570 caused the accumulation of prostate cancer cells as well as epidermoid carcinoma cells in the G2/M phase, however ... normal cells. The efficacy of…
differentiation of androgen-dependent cells and increases the risk for development of benign prostatic hyperplasia and prostate cancer. The recovery of testosterone production and regeneration helps make a decrease…
differentiation of androgen-dependent cells and increases the risk for development of benign prostatic hyperplasia and prostate cancer. The recovery of testosterone production and regeneration helps make a decrease…
Introduction and Objectives: Prostate cancer (CaP) affects 1 in 7 men in their life time. African American (AA) men have significantly higher incidence and mortality from CaP compared to Caucasian
Prostate cancer (PCa) is the 2nd leading cause of cancer-related male deaths in the US. Clinicians lack effective clinical options for advanced disease and metastatic PCa remains incurable ... poorly understood how…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.